SAR and Binding Mode for CXCR4 Antagonists Based on an Arg-Arg-Nal Tripeptide Motif

被引：0
|
作者：
Zachariassen, Z. G. [1 ]
Thiele, S. [2 ]
Rosenkilde, M. M. [2 ]
Hauge, B. E.
Vabeno, J. [1 ]
机构：
[1] Univ Tromso, Fac Hlth Sci, Dept Pharm, N-9037 Tromso, Norway
[2] Univ Copenhagen, Fac Hlth Sci, Mol Pharmacol Lab, Inst Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark
来源：
BIOPOLYMERS | 2011年 / 96卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：492 / 492
页数：1
相关论文
共 50 条
  • [31] Design, synthesis, and biological characterization of a new class of symmetrical polyamine-based small molecule CXCR4 antagonists
    Fang, Xiong
    Meng, Qian
    Zhang, Huijun
    Liang, Boqiang
    Zhu, Siyu
    Wang, Juan
    Zhang, Chaozai
    Huang, Lina S.
    Zhang, Xingquan
    Schooley, Robert T.
    An, Jing
    Xu, Yan
    Huang, Ziwei
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 200
  • [32] Synthesis and evaluation of bifunctional anti-HIV agents based on specific CXCR4 antagonists-AZT conjugation
    Tamamura, H
    Omagari, A
    Hiramatsu, K
    Kanamoto, T
    Gotoh, K
    Kanbara, K
    Yamamoto, N
    Nakashima, H
    Otaka, A
    Fujii, N
    BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (08) : 2179 - 2187
  • [33] Discovery of N-Alkyl Piperazine Side Chain Based CXCR4 Antagonists with Improved Drug-like Properties
    Tahirovic, Yesim A.
    Truax, Valarie M.
    Wilson, Robert J.
    Jecs, Edgars
    Nguyen, Huy H.
    Miller, Eric J.
    Kim, Michelle B.
    Kuo, Katie M.
    Wang, Tao
    Sum, Chi S.
    Cvijic, Mary E.
    Schroeder, Gretchen M.
    Wilson, Lawrence J.
    Liotta, Dennis C.
    ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (05): : 446 - 451
  • [34] Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy
    Zhao, Ruogang
    Liu, Jianhao
    Li, Zhaohuan
    Zhang, Wenhui
    Wang, Feng
    Zhang, Bo
    PHARMACEUTICS, 2022, 14 (08)
  • [35] Design, Synthesis, and Pharmacological Evaluation of Second-Generation Tetrahydroisoquinoline-Based CXCR4 Antagonists with Favorable ADME Properties
    Nguyen, Huy H.
    Kim, Michelle B.
    Wilson, Robert J.
    Butch, Christopher J.
    Kuo, Katie M.
    Miller, Eric J.
    Tahirovic, Yesim A.
    Jecs, Edgars
    Truax, Valarie M.
    Wang, Tao
    Sum, Chi S.
    Cvijic, Mary E.
    Schroeder, Gretchen M.
    Wilson, Lawrence J.
    Liotta, Dennis C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (16) : 7168 - 7188
  • [36] Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonists
    Tamamura, H
    Hiramatsu, K
    Mizumoto, M
    Ueda, S
    Kusano, S
    Terakubo, S
    Akamatsu, M
    Yamamoto, N
    Trent, JO
    Wang, ZX
    Peiper, SC
    Nakashima, H
    Otaka, A
    Fujii, N
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2003, 1 (21) : 3663 - 3669
  • [37] Design, synthesis and structure-activity relationship of ketoheterocyclic based factor Xa inhibitors .4. Structures based on the (D)-Phe-Gly-Arg tripeptide sequence
    Zhu, BY
    Huang, WR
    Martelli, A
    Gunn, AC
    Wong, PW
    Sinha, U
    Scarborough, RM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 101 - MEDI
  • [38] Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis
    Thiele, S.
    Mungalpara, J.
    Steen, A.
    Rosenkilde, M. M.
    Vabeno, J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (23) : 5313 - 5329
  • [39] Structure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonists
    Adlere, I.
    Sun, S.
    Zarca, A.
    Roumen, L.
    Gozelle, M.
    Viciano, C. Perpina
    Caspar, B.
    Arimont, M.
    Bebelman, J. P.
    Briddon, S. J.
    Hoffmann, C.
    Hill, S. J.
    Smit, M. J.
    Vischer, H. F.
    Wijtmans, M.
    de Graaf, C.
    de Esch, I. J. P.
    Leurs, R.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 162 : 631 - 649
  • [40] Heparin Oligosaccharides Inhibit Chemokine (CXC Motif) Ligand 12 (CXCL12) Cardioprotection by Binding Orthogonal to the Dimerization Interface, Promoting Oligomerization, and Competing with the Chemokine (CXC Motif) Receptor 4 (CXCR4) N Terminus
    Ziarek, Joshua J.
    Veldkamp, Christopher T.
    Zhang, Fuming
    Murray, Nathan J.
    Kartz, Gabriella A.
    Liang, Xinle
    Su, Jidong
    Baker, John E.
    Linhardt, Robert J.
    Volkman, Brian F.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (01) : 737 - 746
12345